In:
The Journal of Immunology, The American Association of Immunologists, Vol. 184, No. 1_Supplement ( 2010-04-01), p. 36.3-36.3
Abstract:
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1), also known as plasma cell (PC) alloantigen 1 (PC-1), is expressed on PCs and many non-lymphoid tissues. ENPP1 hydrolyzes NTP to generate NMP and pyrophosphate (PPi). PPi is an important factor for controlling mineralization of the bone. In addition, ENPP1 directly associates with the insulin receptor and regulates insulin receptor signaling. Abnormal expression of ENPP1 has been associated with diabetes and insulin resistance. Although ENPP1 was first identified in PCs, its expression and function in B lineage cells remains poorly understood. Here we describe a previously unknown expression pattern of ENPP1 in murine late stage B cells. By using an anti-ENPP1 mAb and flow cytometry, we found that the expression levels of ENPP1 in early and mature naïve B cells were relatively low. However, germinal center (GC) B cells, PCs and memory B cells expressed 2-4-fold more ENPP1 than resting B cells. Moreover, gene expression profiling studies of primary lymphomas in NFS.V+ congenic mice revealed high expression levels of ENPP1 in plasmacytomas, immunoblastic lymphomas, and centroblastic-follicular lymphoma types, corresponding with their PC and GC origins. These studies demonstrate that ENPP1 can be a useful marker for identification of stages in GC and post-GC cell differentiation and of lymphomas with a GC or PC origin. The function of ENPP1 in B cells is currently under investigation.
Type of Medium:
Online Resource
ISSN:
0022-1767
,
1550-6606
DOI:
10.4049/jimmunol.184.Supp.36.3
Language:
English
Publisher:
The American Association of Immunologists
Publication Date:
2010
detail.hit.zdb_id:
1475085-5
Permalink